Richmond, CA, United States of America

Edward Brooks

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Siemens Healthcare Diagnostics Gmbh. Active years: 2013.


% Patents Active = 100.0


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Edward Brooks: Innovator in Heteropolynucleotide Duplexes

Introduction

Edward Brooks is a notable inventor based in Richmond, CA (US). He has made significant contributions to the field of molecular biology, particularly in the development of heteropolynucleotide duplexes.

Latest Patents

Edward Brooks holds a patent for "Heteropolynucleotide duplexes with purine—purine base pairing." This invention relates to stable anti-parallel heteropolynucleotide duplexes, which comprise a plurality of complementary purine-purine nucleobase dyads. The nucleobase is coupled to a pentose sugar backbone. The patent also includes methods for hybridizing two heteropolynucleotide molecules to form such purine-purine nucleobase dyads, as well as kits and solid supports that incorporate these dyads. He has 1 patent to his name.

Career Highlights

Edward Brooks is currently employed at Siemens Healthcare Diagnostics GmbH, where he continues to innovate and contribute to advancements in healthcare diagnostics. His work focuses on the intersection of biotechnology and healthcare, aiming to improve diagnostic methods and tools.

Collaborations

Edward has collaborated with notable colleagues, including Maria Albalos and Thomas Battersby, who share his commitment to advancing scientific research and innovation.

Conclusion

Edward Brooks exemplifies the spirit of innovation in the field of molecular biology through his groundbreaking work on heteropolynucleotide duplexes. His contributions are paving the way for future advancements in healthcare diagnostics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…